key: cord-0744993-jgzvr2yg
authors: Kitajima, Heita; Hirashima, Tomonori; Suzuki, Hidekazu; Arai, Tsuyoshi; Tamura, Yoshitaka; Hashimoto, Shoji; Morishita, Hiroshi; Matsuoka, Hiroto; Kashiwa, Yozo; Han, Yuki; Minamoto, Seijiro; Tanaka, Toshio; Nagai, Takayuki
title: Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study
date: 2021-05-11
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2021.05.002
sha: 51ec91a8592a8cebdad6c0dfbadfb580ef38c91c
doc_id: 744993
cord_uid: jgzvr2yg

Introduction Japan is facing the threat of medical system collapse due to the rapid spread of coronavirus disease 2019 (COVID-19). The present scoring system may help assess disease severity and oxygen supply requirements in COVID-19 patients. Methods Data on patient characteristics at baseline and throughout hospitalization for COVID-19 were extracted from medical records. Disease severity was dichotomized into two categories without or with oxygen supply as asymptomatic, mild, and moderate illness (AMMI), and severe and critical illness (CSI). The AMMI and CSI groups were compared. Predictors of disease severity, previously identified in the outpatient setting, were included in multivariable logistic regression analysis; the obtained coefficients were converted to integers and assigned a score. Results A total of 206 patients diagnosed with COVID-19 were included in this study. Correlation between COVID-19 severity and medical information was examined by comparing AMMI and CSI. Age, hemodialysis, and C-reactive protein (CRP) levels were candidate predictors of the need for oxygen supply in patients with COVID-19. Coefficients associated with age, hemodialysis, and CRP were as follows: 1×age (in years, coded as 0 for values of <50, and as 1 for values of ≥50) + 1× hemodialysis (coded as 0 for “no”, and as 1 for “yes”) + 1×CRP (in mg/dL, coded as 0 for values of <1.0, and as 1 for values of ≥1.0). Patients with scores of ≥2 points required oxygen supply (sensitivity, 68.4%; specificity, 79.0%) Conclusion The present model can help predict disease severity and oxygen requirements in COVID-19 patients in Japan.

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, Hubei Province, China, and has spread worldwide shortly thereafter [1] . On March 11, 2020 , the World Health Organization declared the COVID-19 outbreak a pandemic. Globally, as of January 17, 2021, there have been 92,506,811and 2,001,773 confirmed cases and associated deaths, respectively, reported worldwide [2] . The corresponding values for Japan, as of January 17, 2021, are 315,910 and 4,380, respectively [2] . Despite global efforts to contain the pandemic, several countries including Japan, are facing the threat of medical system collapse [3] [4] [5] .

Most COVID-19 patients are concurrently asymptomatic and infectious [6] .

However, COVID-19 is associated with high morbidity and mortality rates among symptomatic patients. Most patients that rapidly develop acute respiratory distress syndrome require mechanical ventilation; a high proportion of patients with the severe disease die as a result of it [7, 8] . To prevent medical system collapse, patients likely to develop severe or critical illness should be identified and hospitalized. Previous studies have proposed prediction models focused on COVID-19 diagnosis and prognosis in the general population [9] ; however, no model has been proposed to date for predicting disease severity and the need for oxygen supply, which correspond to the need for hospitalization.

In Japan, the number of acute beds per 1,000 people is larger than that in other countries that are members of the Organization for Economic Co-operation and Development (OECD) [10] . However, the number of physicians per 1,000 people ranks Japan in the middle among the OECD member countries [11] . In addition, in Japan, COVID-19 has been designated as a Category II infectious disease under the Infectious Diseases Control Law; this means that infected patients are required to either be hospitalized or isolated at home or specialized hotels. Given these requirements, effective screening of high-risk patients is required in Japan to prevent medical system collapse.

This retrospective study aimed to develop a scoring system that helps effectively and efficiently identify patients at risk of severe COVID-19 in the outpatient setting, including those likely to require oxygen supply, as relevant in the Japanese context.

The study protocol was approved by the Institutional Review Board of the Osaka Habikino Medical Center (approval no. 1057). This study was conducted according to the tenets of the 1964 Declaration of Helsinki and its later amendments. This study was performed based on the institutional opt-out policy (http://www.ra.opho.jp/hospital/110/), which is an alternative to acquiring informed consent from patients.

Consecutive adult Japanese (≥18 years) patients diagnosed with SARS-CoV-2 viral infection were included in this study. Patients of foreign origin or aged <18 years were excluded from this study. Patients who were already on oxygen support at the time of admission were excluded from this study. Therefore, in this study, we selected the patients who were admitted without oxygen inhalation to the Osaka Habikino Medical Center between February 20 and November 16, 2020.

The genetic detection of SARS-CoV-2 was performed using polymerase chain reaction or loop-mediated isothermal amplification at our institution or the Osaka Institute of Public Health.

We extracted data on the following variables from the patients' medical records: ). Furthermore, we extracted information on laboratory findings obtained on the day of or before hospitalization, specifically: white blood cell count, neutrophil count, lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet count, serum albumin levels, aspartate aminotransferase (AST) levels, alanine aminotransferase (ALT) levels, lactate dehydrogenase (LDH) levels, blood urea nitrogen (BUN) levels, creatinine levels, C-reactive protein (CRP) levels, ferritin levels, D-dimer levels, Krebs von den Lungen-6 (KL-6) protein levels, and random blood sugar (RBS) levels.

J o u r n a l P r e -p r o o f COVID-19 severity was defined according to the National Institutes of Health COVID-19 treatment guidelines [12] . Patients with asymptomatic, mild, or moderate illness (AMMI) were those that did not require oxygen supply at all during hospitalization. In contrast, patients categorized as having a severe or critical illness (CSI) were those that required oxygen supply during hospitalization. Disease severity was evaluated throughout hospitalization and peak severity was used to define patient severity status in this study.

Antiviral and anti-inflammatory treatments were administered to most patients, following our institution's COVID-19 treatment guidelines (Table 1) . 

Risk factors and stratification scores for oxygen supply need among Japanese patients with COVID-19 were evaluated based on clinical characteristics, and laboratory on admission day. Since hospitalization is mandatory when oxygen supply is required, the need for oxygen was the primary outcome and indicator of disease severity. 

A total of 206 patients diagnosed with COVID-19 were included in this study ( Test coefficients associated with age, hemodialysis status, and the levels of CRP were derived from logistic regression analysis and converted into integers; subsequently, they were assigned a score of 1, 1, and 1, respectively, yielding the risk score formula of 1×age (in years, coded as 0 for values of <50, and as 1 for values of ≥50)+ 1× hemodialysis (coded as 0 for "no", and as 1 for "yes") + 1×CRP (in mg/dL, coded as 0 for values of <1.0, and as 1 for values of ≥1.0) ( Table 4 ).

The area under the curve for this clinical risk score was 0.809; the risk score ranged from 0 to 3 points. Patients with scores of ≥2 points required oxygen supply and hospitalization (sensitivity, 68.4%; specificity, 79.0%) ( Table 5 and Figure 2 ). Previous studies [13] [14] [15] [16] that developed prediction models of COVID-19 progression considered comorbidity status, blood cell count or ratios, and CRP levels.

These factors [13] [14] [15] [16] may help determine the need for hospitalization and oxygen supply.

The present scoring model should be verified in a validation cohort. We intend to perform prospective and multi-center studies to develop a model predicting the need for hospitalization in Japanese patients with COVID-19.

The present study has several limitations that must be considered when interpreting its findings. First, this study was retrospective and based on a single center.

Second, because of the lack of a definite treatment policy for COVID-19 in Japan, treatment was selected according to the institution's treatment guideline. Third, the presented model was not tested in a validation cohort.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

J o u r n a l P r e -p r o o f 

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

World Health Organization Coronavirus Disease (COVID-19) Dashboard

COVID-19: a novel coronavirus and a novel challenge for critical care

Critical care utilization for the COVID-19

Early experience and forecast during an emergency response

Overloaded hospitals: 'Medical care system is already in a state of collapse'. (Issue date

Presumed asymptomatic carrier transmission of COVID-19

Covid-19 in critically ill patients in the Seattle Region -case series

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus sisease 2019 pneumonia in Wuhan, China

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan

Development and external validation of a prognostic tool for COVID-19 critical disease

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Prediction for progression risk in patients with COVID-19 pneumonia: The CALL score

The authors thank the patients and their families and are grateful to all members of the